Healthcare & Life Sciences
Heqet Therapeutics
series-a
series-a
Stage
1
Investors
About
Heqet Therapeutics develops RNA-based therapies aimed at inducing cardiac regeneration to repair heart injuries.
Explore Heqet Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.